Overview
Location
United Kingdom, England, Hertford
Employees
1-10
Founded date
2018
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 8, 2021 | Neurocrine Biosciences : Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone | BURNABY, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that its collaboration to develop treatments for epilepsy with Neurocrine... |
| Sep 8, 2021 | Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone | BURNABY, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that its collaboration to develop treatments for epilepsy with Neurocrine... |
Reviews 0
FAQ about Compliance as a Service
When was Compliance as a Service founded?
Compliance as a Service was founded in 2018.
What has the press written about Compliance as a Service?
Parsers VC has collected 3 articles mentioning Compliance as a Service, among them “Neurocrine Biosciences : Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone” (Sep 8, 2021) and “Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone” (Sep 8, 2021).
Is Compliance as a Service still active?
Yes, Compliance as a Service is active; its latest activity on Parsers VC dates from Nov 1, 2021.